Researchers examined the relationship between lncRNA H19 and Insulin-Like Growth Factor 1 Receptor (IGF-1R) mRNA gene expressions in lymph nodes from HCC and T2DM patients to test whether there may be a pathophysiological link between these two diseases that may become a therapeutic target for both. This evidence concerns the gene IGF1R and hepatocellular carcinoma.